HRT Financial
PLXP

HRT Financial’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

HRT Financial’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-86,942
Closed -$14K – 3492
2022
Q4 		$14K Buy
+86,942
New +$36.4K ﹤0.01% 2200
2022
Q3 		– Sell
-14,795
Closed -$35K – 3768
2022
Q2 		$35K Buy
+14,795
New +$41.1K ﹤0.01% 2548

Other funds holding PLXP

Park West Asset Management
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
University of Texas/Texas AM Investment Management Co (UTIMCO)
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $863M AUM 30.35% 1-Year Est. Return
Synovus Financial
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return

HRT Financial's PLXP Position: Q1 2023 in Review

HRT Financial sold out of PLx Pharma Inc. Common Stock (PLXP) in Q1 2023, closing a stake of 86,942 shares — an estimated $14K sold.

HRT Financial first reported a position in PLXP in Q2 2022 and held it in 2 quarters. The position peaked at $35K in Q2 2022. 34 funds tracked by Wall St. Rank hold PLXP as of Q1 2023.

  • HRT Financial reported no remaining PLx Pharma Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • HRT Financial sold 86,942 PLx Pharma Inc. Common Stock shares in Q1 2023, an estimated $14K.
  • HRT Financial first reported a position in PLx Pharma Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • HRT Financial's PLx Pharma Inc. Common Stock position peaked at $35K in Q2 2022.
  • 34 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.